Is West Pharmaceutical Services, Inc. a good dividend stock?

West Pharmaceutical Services, Inc. (WST) is a dividend-paying stock with a current dividend yield of 0.25%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is WST's dividend yield?

The dividend yield for WST stock is currently 0.25%.

How much does WST pay in dividends per year?

West Pharmaceutical Services, Inc. pays an annual dividend of $0.8700 per share over the trailing twelve months.

How often does WST pay dividends?

WST stock pays dividends quarterly.

Is WST's dividend growing?

West Pharmaceutical Services, Inc.'s 3-year dividend CAGR is 5.07%.

WST Stock Price, Chart, Stats & News

West Pharmaceutical Services, Inc.

Save

Overview Dividend safety Dividends Fundamentals

West Pharmaceutical Services, Inc. (WST) is a dividend-paying stock with a current dividend yield of 0.25% as of Jun 29, 2026. It pays $0.8700 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 5.36% 5-year compound annual rate.

25.06B

Market cap

44.50x

Current P/E

40.82x

Forward P/E

0.25%

Dividend yield

$0.8700

WST dividend

Dividend safety

Strong

Dividend coverage looks healthy — WST pays out about 11% of earnings.

See the safety analysis

WST chart

Loading chart...

Fundamentals

Gross margin	35.89%
Operating margin	20.07%
Pretax margin	20.02%
Net margin	16.06%
Effective tax rate	19.76%
ROA	11.56%
ROE	16.68%
D/E	0.10x
Interest coverage ratio	1028.17x

All financials

WST valuation

P/E	44.50x
P/S	5.70x
P/B	5.54x
P/CF	23.31x
P/FCF	37.38x
P/OCF	23.31x
PEG	60.49x
EV multiple	23.19x

About

Health care

Sector

Medical - Instruments & Supplies

Industry

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements.